Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/13/2025

Initial Management of Hip Arthritis Pain

Pharmacological Management

  • The American College of Rheumatology recommends acetaminophen (up to 4g/day) as the initial oral analgesic for mild to moderate hip osteoarthritis pain due to its favorable safety profile 1, 2
  • NSAIDs should be added or substituted at the lowest effective dose when patients respond inadequately to acetaminophen, as suggested by the European League Against Rheumatism 3, 4
  • For patients with increased gastrointestinal risk, consider either non-selective NSAIDs plus a gastroprotective agent or a selective COX-2 inhibitor, according to the American Gastroenterological Association 4, 5
  • Intra-articular corticosteroid injections may be considered for patients with flares unresponsive to oral analgesics and NSAIDs, as recommended by the American College of Rheumatology 5, 2
  • Opioid analgesics with or without acetaminophen are useful alternatives when NSAIDs/COX-2 inhibitors are contraindicated, ineffective, or poorly tolerated, as stated by the American Pain Society 6, 2
  • Tramadol may be considered as an alternative when other options have failed, according to the European League Against Rheumatism 3, 2

Non-Pharmacological Approaches

  • Provide education about the condition and self-management strategies, as recommended by the Arthritis Foundation 3, 2
  • Consider the use of walking aids (cane, walker) to reduce joint load and improve mobility, as suggested by the American College of Rheumatology 3, 2
  • Apply local heat or cold for symptomatic relief, according to the American Pain Society 2
  • Recommend land-based cardiovascular and/or resistance exercise under supervision of a physical therapist, as recommended by the American College of Sports Medicine 3, 2
  • Suggest aquatic exercise as an alternative, particularly for patients with mobility limitations, according to the Arthritis Foundation 3, 2
  • Advise weight loss for overweight or obese patients, as recommended by the American Heart Association 3, 2

Special Considerations

  • Monitor for gastrointestinal adverse effects with NSAIDs, particularly in elderly patients or those with comorbidities, as cautioned by the American Gastroenterological Association 1, 4
  • Be cautious with acetaminophen in patients with liver disease, according to the American Liver Foundation 1
  • Limit opioid use due to higher rates of side effects including gastrointestinal upset, constipation, and dizziness, as warned by the American Pain Society 4
  • Avoid relying solely on opioids for pain management, as they should be reserved for patients who have not responded to other modalities, according to the American College of Rheumatology 3
  • Don't recommend glucosamine and chondroitin for patients with hip OA, as these are not supported by current guidelines, as stated by the National Institutes of Health 3, 2
  • Recognize that intra-articular hyaluronic acid injections are not recommended for hip OA due to insufficient evidence, according to the American College of Rheumatology 2

Follow-up Recommendations

  • Refer patients to a rheumatologist or orthopedic specialist for ongoing management if pain persists despite initial interventions, as recommended by the American College of Rheumatology 3
  • Consider total hip replacement for patients with radiographic evidence of hip OA who have refractory pain and disability despite conservative management, according to the American Academy of Orthopaedic Surgeons 7, 2
  • Recommend participation in self-management programs to improve long-term outcomes, as suggested by the Arthritis Foundation 3, 2